Observational Study to Assess the Efficacy and Tolerability of Eptadone®, in Heroin Addicted Patients in a MMT

NCT ID: NCT02062723

Last Updated: 2014-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

515 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2013-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The efficacy and tolerability of Eptadone® in the context of a maintenance program will be evaluated in an observational prospective, multicenter study, in heroin addicted patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

515 patients have been selected among all patients addicted to heroin according ICD-10, in maintenance treatment with Eptadone, observed in the involved sites. The investigators have used the treatment schemes with Eptadone conform to the registered use.

The enrollment has been competitive. Patients met incl/excl and that have signed the informed consent have been observed for 1 year. Follow up visits have been performed according to routine procedures, for patients related to the centres at 3/6/12 months post V1. During the visits patients have been assessed by validated and used as clinical practice questionaries. Safety and tolerability have been assessed through the collection of adverse reactions and of laboratory tests.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heroin Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

pts addicted to heroin in MMT

patients addicted to heroin who have undertaken methadone maintenance treatment

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both sexes
* Over 18 years of age
* Patients with a diagnosis of heroin addiction, according to ICD-10 (International Classification of Diseases-10)
* Patients who receive a "maintenance treatment" with Eptadone® since at least one month
* Accession to the observational study by informed consent

Exclusion Criteria

* Inability to follow the observation and to understand study procedure and follow them
* Diagnosis of:

* Decompensated psychotic disorders,
* Epileptic attacks, not related with drug abuse,
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Facharzt für Allgemeinmedizin

Bad Honnef, , Germany

Site Status

Praxis Turmstrasse

Berlin, , Germany

Site Status

Praktischer Arzt

Bonn, , Germany

Site Status

Arzt für Allgemeinmedizin

Bremen, , Germany

Site Status

Psychiatrie

Bremen, , Germany

Site Status

Praxis

Cologne, , Germany

Site Status

Dres. Beck & Hummel Artzegemeinschaft

Fürstenfeldbruck, , Germany

Site Status

Gemeinschaftspraxis fur Neurologie, Psychiatrie und Suchtmedizin Poliklinik Silberhohe

Halle, , Germany

Site Status

Universitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik fur Psychiatrie und Psychotherapie

Hamburg, , Germany

Site Status

Arzt für Allgemeinmedizin

Hamburg, , Germany

Site Status

Gemeinschaftspraxis Suchtmedizin

Hamburg, , Germany

Site Status

Fachgebiet Allgemeinmedizin

Hamburg, , Germany

Site Status

Praxiszentrum Friedrichsplatz

Kassel, , Germany

Site Status

Facharzt für Psychiatrie Psychotherapie

Lehrte, , Germany

Site Status

Facharzt für Innere Medizin

Leipzig, , Germany

Site Status

Praxiszentrum im Tal

München, , Germany

Site Status

Praxis

München, , Germany

Site Status

Concept Schwerpunktpraxis Sucht

München, , Germany

Site Status

Facharzt fur Psychiatrie

Münster, , Germany

Site Status

Hausärztliche Praxis

Regensburg, , Germany

Site Status

Bezirksklinik Regensburg

Regensburg, , Germany

Site Status

Psychatrie

Ulm, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MOLT-2009-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Methadone Maintenance for Prisoners
NCT00378079 COMPLETED PHASE3
Clinical Rescue Protocol - 2
NCT00000206 COMPLETED PHASE2
Buprenorphine Maintenance Protocol - 1
NCT00000205 COMPLETED PHASE3